Clinical Trials Directory

Trials / Completed

CompletedNCT00608829

GORE TAG® Thoracic Endoprosthesis - 45 mm for the Treatment of Aneurysms of the Descending Thoracic Aorta

Evaluation of the GORE TAG® Thoracic Endoprosthesis - 45 mm for the Primary Treatment of Aneurysms of the Descending Thoracic Aorta

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
23 (actual)
Sponsor
W.L.Gore & Associates · Industry
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

The objective of this study is to assess the safety and efficacy of the 45 mm TAG device in subjects with aneurysms of the descending thoracic aorta.

Conditions

Interventions

TypeNameDescription
DEVICEGORE TAG® Thoracic EndoprosthesisImplant

Timeline

Start date
2007-02-01
Primary completion
2009-08-01
Completion
2014-09-01
First posted
2008-02-06
Last updated
2015-03-05
Results posted
2010-09-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00608829. Inclusion in this directory is not an endorsement.

GORE TAG® Thoracic Endoprosthesis - 45 mm for the Treatment of Aneurysms of the Descending Thoracic Aorta (NCT00608829) · Clinical Trials Directory